1. Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds. Issue 7 (5th June 2013) Authors: Cherry, Jonathan J.; Osman, Erkan Y.; Evans, Matthew C.; Choi, Sungwoon; Xing, Xuechao; Cuny, Gregory D.; Glicksman, Marcie A.; Lorson, Christian L.; Androphy, Elliot J. Journal: EMBO molecular medicine Issue: Volume 5:Issue 7(2013:Jul.) Page Start: 1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug‐like compounds. Issue 7 (5th June 2013) Authors: Cherry, Jonathan J.; Osman, Erkan Y.; Evans, Matthew C.; Choi, Sungwoon; Xing, Xuechao; Cuny, Gregory D.; Glicksman, Marcie A.; Lorson, Christian L.; Androphy, Elliot J. Journal: EMBO molecular medicine Issue: Volume 5:Issue 7(2013:Jul.) Page Start: 1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy. (5th January 2017) Authors: Khairallah, Marie-Therese; Astroski, Jacob; Custer, Sarah K.; Androphy, Elliot J.; Franklin, Craig L.; Lorson, Christian L. Journal: Human molecular genetics Issue: Volume 26:Number 5(2017:Mar. 01) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗